VEGFA and breast carcinoma: Furthermore, Bakr et al. investigated the diagnostic relevance of miR-373 in patients with breast cancer, going beyond its identification as a diagnostic biomarker to examine its interactions with the target genes vascular endothelial growth factor (VEGF) and cyclin D1.